PHARMING GROUP NV - ADR (PHAR) Stock Income Statement
NASDAQ:PHAR - Nasdaq - US71716E1055 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 320.71M | 297.20M | 245.32M | 205.62M | 198.87M | |||
| Cost Of Goods | 35.34M | 35.40M | 25.21M | 17.56M | 21.14M | |||
| Gross Profit | 285.37M | 261.80M | 220.10M | 188.06M | 177.73M | |||
| Operating Expenses | 276.93M | 265.39M | 241.85M | 177.69M | 153.73M | |||
| Research and Development | 83.67M | 81.47M | 66.81M | 50.87M | 62.09M | |||
| Selling, General, and Administrative Expenses | 195.47M | 175.06M | 166.11M | 120.29M | 85.09M | |||
| Operating Income | 8.45M | -3.59M | -21.75M | 10.37M | 24.00M | |||
| Interest Income/Expense | -4.30M | 1.28M | -6.63M | -3.25M | 9.52M | |||
| Other Income/Expense | N/A | -1.15M | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | -5.03M | 16.36M | 7.87M | -10.44M | |||
| Income Before Taxes | -3.66M | -8.49M | -12.01M | 14.99M | 23.08M | |||
| Income Tax | 10.63M | 3.35M | -1.46M | 1.31M | 7.08M | |||
| Net Income | -14.11M | -11.84M | -10.55M | 13.67M | 16.00M | |||
| EBITDA | 21.18M | 12.48M | -5.83M | 23.55M | 43.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.21 | -0.17 | -0.16 | 0.19 | 0.22 | |||
| Non GAAP EPS | -0.26 | -0.23 | -0.16 | N/A | 0.24 | |||
| Statistics | ||||||||
| Gross Profit Margin | 88.98% | 88.09% | 89.72% | 91.46% | 89.37% | |||
| Profit Margin | -4.40% | -3.98% | -4.30% | 6.65% | 8.04% | |||
| Operating Profit Margin | 2.63% | -1.21% | -8.87% | 5.04% | 12.07% | |||
All data in USD